FRESNO, Calif. (KMJ) — Despite a greater acceptance of generic drugs, health insurers are spending substantially more on prescription medications.
According to a new study from the Blue Cross Blue Shield Association, costs have risen by more than 70 percent since 2010.
Much of that is being attributed to high cost specialty drugs, used to treat Hepatitis C, autoimmune disorders, cancer, asthma, and diabetes.
The study is being disputed by the Pharmaceutical Research and Manufacturers of America group, who says medicine spending is on the decline.
Aaron Abeytia anchors afternoon newscasts on News/Talk 580 & 105.9 KMJ. Read More…
Copyright © 2016 Cumulus Media. All Rights Reserved.
